EUVIMEDEUVIMED entdecken
Crossref

Associations between plasma complement C1q and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: The CABLE study

Rong-Ji Xue iD, Pei-Yang Gao iD, Yan-Ming Chen iD, Ying Liu, Bao-Lin Han iD, Yi-Ming Huang iD, Yin-Chu Mi iD, Rui-Ping Cui iD, Yu-Jing Lin iD, Zuo-Teng Wang iD, Chen-Chen Tan iD, Ya-Nan Ou und 1 weitere

Journal of Alzheimer’s Disease · 2025

DOI: 10.1177/13872877251322808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Rong-Ji Xue und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Complement C1q, Amyloid beta-Peptides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Taishan Scholar Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

C1q is a promoter of the classical pathway of complement and its massive expression may be associated with the development of Alzheimer's disease (AD). However, the relationships between C1q and the major pathological challenges, including amyloid-β (Aβ) and tau deposition, remain undetermined in the preclinical AD phase.

Objective

This study aims to investigate the connections between plasma C1q and CSF AD biomarkers.

Methods

The cognitively intact participants (N = 1264) from the Chinese Alzheimer's Biomarker and LifestylE (CABLE) study were categorized into four groups, including Stage 0 [normal Amyloid-β 1–42 (Aβ 1–42 ), Phosphorylated-tau (P-tau) and Total-tau (T-tau)], Stage 1 (abnormal Aβ 1–42, but normal P-tau or T-tau), Stage 2 (abnormal Aβ 1–42 and abnormal P-tau or T-tau), and suspected non-Alzheimer disease pathology (SNAP) (abnormal P-tau or T-tau, but normal amyloid levels). The changes in plasma C1q levels among these groups and the correlation between C1q levels and cerebrospinal fluid (CSF) AD biomarkers were performed.

Results

The results demonstrated plasma C1q levels are lower in Stage 0 (p = 0.010) and SNAP (p < 0.001) compared with Stage 1. A significant association between C1q levels and CSF AD pathology, including Aβ 1–42 (β = −0.143, p < 0.001), Aβ 1–42 /Aβ 1–40 (β = −0.173, p < 0.001), P-tau/Aβ 1–42 (β = 0.156, p < 0.001), and T-tau/Aβ 1–42 (β = 0.130, p < 0.001) has been identified.

Conclusions

The current research elucidates a positive correlation between elevated plasma C1q levels and CSF Aβ pathology, with C1q amplifying concomitantly with the pathological and clinical progression of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseComplement C1qAmyloid beta-PeptidesHumansFemaleMaleBiomarkerstau ProteinsAgedPeptide FragmentsMiddle AgedAged, 80 and over

Stichwörter der Autor:innen

Alzheimer's diseaseC1qamyloid-βcerebrospinal fluidcomplement

Substanzen

Complement C1qBiomarkersAmyloid beta-Peptidestau ProteinsPeptide Fragmentsamyloid beta-protein (1-42)MAPT protein, human

Autor:innen und Institutionen

  • Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.
  • Department of Neurology & Innovation Center for Neurological Disorders, Xuanwu Hospital, National Center for Neurological Disorders, Capital Medical University, Beijing, China.
  • Department of Neurology, Qingdao Municipal Hospital, Dalian Medical University, Qingdao, China.
  • Department of Neurology, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, China.
  • Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China.

ORCID-Profile: Rong-Ji Xue, Pei-Yang Gao, Yan-Ming Chen, Bao-Lin Han, Yi-Ming Huang, Yin-Chu Mi, Rui-Ping Cui, Yu-Jing Lin, Zuo-Teng Wang, Chen-Chen Tan, Lan Tan

Förderung

  • National Natural Science Foundation of China
  • Taishan Scholar Foundation of Shandong Province

Zitieren

APA

Xue, R. J., Gao, P. Y., Chen, Y. M., Liu, Y., Han, B. L., Huang, Y. M., Mi, Y. C., Cui, R. P., Lin, Y. J., Wang, Z. T., Tan, C. C., Ou, Y. N., & Tan, L. (2025). Associations between plasma complement C1q and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: The CABLE study. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251322808

Vancouver

Xue RJ, Gao PY, Chen YM, Liu Y, Han BL, Huang YM, et al. Associations between plasma complement C1q and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: The CABLE study. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251322808

BibTeX
@article{Xue2025,
  author = {Xue, Rong-Ji and Gao, Pei-Yang and Chen, Yan-Ming and Liu, Ying and Han, Bao-Lin and Huang, Yi-Ming and Mi, Yin-Chu and Cui, Rui-Ping and Lin, Yu-Jing and Wang, Zuo-Teng and Tan, Chen-Chen and Ou, Ya-Nan and Tan, Lan},
  title = {Associations between plasma complement C1q and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: The CABLE study},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  doi = {10.1177/13872877251322808}
}
Kostenlos starten →